TFRC and cancer: In summary, our generation and characterization of the novel HLO1-6H5 monoclonal antibody, its target surface marker of TFRC, and the lung progenitor cell subset that it isolates will provide opportunities to further understand normal lung cell populations and their respective functions and also potentially advance our knowledge of the mechanisms underlying multiple respiratory conditions and cancers of the lung and other tissue systems.